Randal Chase
Director/Board Member bei GEOVAX LABS, INC.
Vermögen: 4 882 $ am 31.03.2024
Profil
Randal D.
Chase's current job is as an Independent Director at GeoVax Labs, Inc. His former jobs include being the President & Chief Executive Officer at North American Vaccine, Inc. from 1998 to 2000, President, CEO & Non-Independent Director at Advanced Proteome Therapeutics Corp.
from 2017 to 2018, President & Chief Executive Officer at Immunovaccine Technologies, Inc. from 2007 to 2011, President & Chief Executive Officer at Pasteur Mérieux Connaught from 1995 to 1998, President & Chief Executive Officer at IMV, Inc. from 2006 to 2011, Chairman at Medicago, Inc. from 2003 to 2013, Executive Chairman at Molecular Templates, Inc. from 2005 to 2006, Chairman at MédiMabs, Inc., Chairman at Glysantis, Inc., Director at Bioject Medical Technologies, Inc. from 2005 to 2009, Non-Executive Director at Acambis Plc from 2002 to 2008, Director at ConjuChem, Inc. from 2004 to 2009, Director at ConjuChem Biotechnologies, Inc. from 2004 to 2009, Director at Rhino Resources, Inc. (Canada) in 2009, Director at Bristol-Myers Squibb Canada Co. from 1978 to 1988, Director at Mirexus Biotechnologies, Inc., Director at Tissue Regeneration Therapeutics, Inc., President at Shire BioChem, Inc. from 2001 to 2004, President at QLT, Inc., Senior Vice President-Vaccines Operations at Biochem Pharma, Inc. from 2001 to 2002, President at Aventis Pasteur Ltd., President at Quadralogic Technologies, Inc. from 1993 to 1995, Senior Vice President at Glaxo Canada, Inc., Senior Vice President-Vaccines Operations at Brioche Parma, and President at Shire Biologics, Inc. His education includes a doctorate degree from the University of British Columbia in 1974 and an undergraduate degree from Bishop's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GEOVAX LABS, INC.
0,11% | 11.03.2024 | 2 441 ( 0,11% ) | 4 882 $ | 31.03.2024 |
Aktive Positionen von Randal Chase
| Unternehmen | Position | Beginn |
|---|---|---|
| GEOVAX LABS, INC. | Director/Board Member | 19.03.2015 |
Ehemalige bekannte Positionen von Randal Chase
| Unternehmen | Position | Ende |
|---|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Chief Executive Officer | 16.04.2018 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Chairman | 01.06.2013 |
| IMV INC. | President | 13.07.2011 |
| Immunovaccine Technologies, Inc. | Chief Executive Officer | 01.01.2011 |
| BIOJECT MEDICAL TECHNOLOGIES INC. | Director/Board Member | 18.12.2009 |
Ausbildung von Randal Chase
| University of British Columbia | Doctorate Degree |
| Bishop's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| GEOVAX LABS, INC. | Health Technology |
| IMV INC. | Health Technology |
| Private Unternehmen | 23 |
|---|---|
Bioject Medical Technologies, Inc.
 Bioject Medical Technologies, Inc. Medical SpecialtiesHealth Technology Bioject Medical Technologies, Inc. develops and manufactures needle-free injection therapy systems. Its products include Biojector 2000, Needle Free Injection System, ZetaJet, Drug Reconstitution System, and Needle-Free Vial Adapter. The company was founded in 1985 and is headquartered in Tigard, OR. | Health Technology |
Shire BioChem, Inc.
 Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Distribution Services |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
North American Vaccine, Inc.
 North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
ConjuChem, Inc.
 ConjuChem, Inc. Pharmaceuticals: MajorHealth Technology ConjuChem, Inc. is a biotechnology company that has developed the Drug Affinity Complex (DAC™) Technology, a platform enabling the rapid creation of improved, patentable drugs from existing small organic compounds or peptides. | Health Technology |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
ConjuChem Biotechnologies, Inc. /Old/
 ConjuChem Biotechnologies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ConjuChem Biotechnologies, Inc. develops peptide based pharmaceuticals to treat diseases such as congestive heart failure, diabetes, HIV/AIDS and human growth deficiencies. The company is a research and development company that develops technology that binds peptides to albumin in order to extend the half life of drugs from minutes to days. ConjuChem Biotechnologies is headquartered in Montréal , Canada. | Health Technology |
| Rhino Resources, Inc. (Canada) | Finance |
Tissue Regeneration Therapeutics, Inc.
 Tissue Regeneration Therapeutics, Inc. BiotechnologyHealth Technology Tissue Regeneration Therapeutics, Inc. operates as a biotechnology company. It develops osteoscaf, a biodegradable and osteoconductive scaffold for use in healing tissue defects. The company is headquartered in Toronto, Canada. | Health Technology |
Biochem Pharma, Inc.
 Biochem Pharma, Inc. Pharmaceuticals: OtherHealth Technology Biochem Pharma, Inc. provides bioinfomatics tools, biotechnology databases and consulting services to the genomics, proteomics and biopharmaceutical industries. They provide the cutting edge strategic intelligence needed to exploit information and to develop future business strategies. | Health Technology |
| Immunovaccine Technologies, Inc. | Health Technology |
| Pasteur Mérieux Connaught | |
| Aventis Pasteur Ltd. | |
Quadralogic Technologies, Inc.
 Quadralogic Technologies, Inc. Medical SpecialtiesHealth Technology Quadralogic Technologies, Inc. manufactures pharmaceutical and herbicide products. | Health Technology |
Molecular Templates, Inc. /Old/
 Molecular Templates, Inc. /Old/ BiotechnologyHealth Technology Molecular Templates, Inc. operates as a holding company that engages in the discovery and development of immunotoxins for the treatment of cancer and other serious diseases. These are capable of targeting validated therapeutic cell surface receptors but also non-traditional targets that cannot be therapeutically targeted by antibodies or small molecules. Its product pipeline consists of lead candidates for non-Hodgkin's lymphoma, multiple myeloma, and breast cancer. The company was founded by Jean Gariépy and Leigh Revers in 2009 and is headquartered in Georgetown, TX. | Health Technology |
| Glaxo Canada, Inc. | |
| Brioche Parma | |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
MédiMabs, Inc.
 MédiMabs, Inc. Miscellaneous Commercial ServicesCommercial Services MédiMabs, Inc. operates as a specialized boutique for antibodies and provides researchers with licensed products. It offers antigen design and strategy, polyclonal antibody development, Cryostorage, vaccine development and antibody validation services. The company was founded by A. Claudio Cuello in 2006 and is headquartered in Montreal, Canada. | Commercial Services |
Mirexus Biotechnologies, Inc.
 Mirexus Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mirexus Biotechnologies, Inc. develops personal care products. The firm specializes in personal care and cosmetics, nutraceuticals and biomedical. The company was founded by John Dutcher, Anton Korenevski, Erzebet Papp-Szabo and Oleg Stukalov and is headquartered in Guelph, Canada. | Health Technology |
Shire Biologics, Inc.
 Shire Biologics, Inc. Pharmaceuticals: MajorHealth Technology Shire Biologics, Inc. is an American company that manufactures pharmaceutical medicines. | Health Technology |
| Glysantis, Inc. |
